SNZ

SphereX, a Decentralized Crypto Exchange, Secures Major Investment from SNZ, Strengthening Support

Retrieved on: 
Wednesday, February 28, 2024

The investment from SNZ comes in addition to the substantial support already provided by Fundamental Labs , further validating SphereX's vision and mission within the rapidly evolving decentralized finance (DeFi) ecosystem.

Key Points: 
  • The investment from SNZ comes in addition to the substantial support already provided by Fundamental Labs , further validating SphereX's vision and mission within the rapidly evolving decentralized finance (DeFi) ecosystem.
  • SphereX aims to revolutionize decentralized trading by offering a seamless and intuitive platform that prioritizes user experience while maintaining the core principles of decentralization, security, and transparency.
  • The investment from SNZ underscores growing confidence in SphereX's innovative approach to decentralized trading.
  • With a strong foundation of support and a clear vision for the future, SphereX is poised to make a significant impact on the decentralized finance space.

Three New Articles in the Journal of Pharmaceutical Analysis Demonstrate the Potential of Natural Compounds to Treat Gastrointestinal Disorders

Retrieved on: 
Tuesday, November 28, 2023

XI'AN, China, Nov. 28, 2023 /PRNewswire/ -- Chronic gastrointestinal (GI) disorders are becoming increasingly common throughout the world, but many of them still lack effective treatment. Researchers have now turned to natural compounds, such as those present in traditional medicines, to search for potential drug candidates for difficult-to-treat diseases. The latest issue of the Journal of Pharmaceutical Analysis (JPA) features three articles that report promising findings and could pave the way to treatments for complex diseases affecting the liver and intestine. 

Key Points: 
  • Researchers have now turned to natural compounds, such as those present in traditional medicines, to search for potential drug candidates for difficult-to-treat diseases.
  • The latest issue of the Journal of Pharmaceutical Analysis (JPA) features three articles that report promising findings and could pave the way to treatments for complex diseases affecting the liver and intestine.
  • The article was available online in July 2023 and published in Volume 13, Issue 9 of JPA in September 2023 .
  • Moreover, Rk2 also restored intestinal barrier function by enhancing NLPR6 signaling in the intestine, demonstrating its multifaceted therapeutic potential.

Puffer Finance Raises $5.5M Seed Funding to Strengthen Ethereum Decentralization & Scalability

Retrieved on: 
Tuesday, August 8, 2023

Secure-Signer previously received support from the Ethereum Foundation in the form of a $120k grant, underscoring its importance within the Ethereum ecosystem.

Key Points: 
  • Secure-Signer previously received support from the Ethereum Foundation in the form of a $120k grant, underscoring its importance within the Ethereum ecosystem.
  • Commenting on the announcement, Amir Forouzani, and Jason Vranek, Founders of Puffer Finance, said: "The rapid advancements in infrastructure and user experience have primed Ethereum for mass adoption.
  • We hope the Puffer Protocol will create a pocket within the validator set where decentralization can thrive.
  • Together and with our community, we will build a flourishing ecosystem true to the values that made Ethereum so special."

Social Future Raised $6M to Build AI-Driven Virtual Social Platform

Retrieved on: 
Thursday, April 6, 2023

Social Future, an AI-driven social metaverse company, is excited to announce that it has successfully raised $6 million in funding.

Key Points: 
  • Social Future, an AI-driven social metaverse company, is excited to announce that it has successfully raised $6 million in funding.
  • Social Future is also a member of OMA3 (Open Metaverse Alliance) , and partners with well-known metaverse companies such as Animoca Brands, Decentraland, and Metajuice.
  • Social Future aims to create the future of social experience with phygital interaction, immersive content, and self-sovereign communities.
  • Social Future's product, MAY ("Meet Another You") , enables immersive social experiences via personalized avatars.

FilSwan Raises $3M USD to Revolutionize & Simplify Building dApps

Retrieved on: 
Monday, January 16, 2023

TORONTO, Jan. 16, 2023 /PRNewswire-PRWeb/ -- FilSwan, a cross-chain infrastructure for web3, is pleased to disclose three million US dollar fundraisings. FilSwan provides services that integrate data, computing, bandwidth, and payment into one suite for Web3 projects.

Key Points: 
  • FilSwan provides services that integrate data, computing, bandwidth, and payment into one suite for Web3 projects.
  • TORONTO, Jan. 16, 2023 /PRNewswire-PRWeb/ -- FilSwan , a cross-chain infrastructure for web3, is pleased to disclose three million US dollar fundraisings.
  • FilSwan provides services that integrate data, computing, bandwidth, and payment into one suite for Web3 projects.
  • A new project on decentralized data science, Lagrange DAO, is incubated by FilSwan and kicked off on Hack FEVM - ETHGlobal. "

Probiotic strain SNZ 1969® helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

Retrieved on: 
Tuesday, November 29, 2022

HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ --Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms.

Key Points: 
  • HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ --Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms.
  • The outcome of this study will be significant to supplement manufacturers as it can help design products to address consumer need for managing IBS symptoms with a scientifically studied probiotic strain.
  • This study was conducted at Apollo Hospitals, Hyderabad, India and published in the International Journal of Basic & Clinical Pharmacology.
  • Intestinal motility study concluded that SNZ 1969 reaches the colon intact and ameliorates intestinal motility and gut microbiota composition.

Probiotic strain SNZ 1969® helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

Retrieved on: 
Tuesday, November 29, 2022

HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ --Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms.

Key Points: 
  • HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ --Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms.
  • The outcome of this study will be significant to supplement manufacturers as it can help design products to address consumer need for managing IBS symptoms with a scientifically studied probiotic strain.
  • This study was conducted at Apollo Hospitals, Hyderabad, India and published in the International Journal of Basic & Clinical Pharmacology.
  • Intestinal motility study concluded that SNZ 1969 reaches the colon intact and ameliorates intestinal motility and gut microbiota composition.

BEAM+ LAB to Become a Web3 Film & Entertainment Universe by Revolutionising Traditional IP Ownership Model

Retrieved on: 
Monday, October 17, 2022

HONG KONG, Oct. 16, 2022 /PRNewswire/ -- With numerous entertainment IP creators entering the Web3 space, BEAM+ LAB stands out as the first decentralised film & entertainment universe that pioneers with its ground-breaking IP co-ownership and "4C" operation model – "co-create", "community", "collaborate" and "commercialise".

Key Points: 
  • HONG KONG, Oct. 16, 2022 /PRNewswire/ -- With numerous entertainment IP creators entering the Web3 space, BEAM+ LAB stands out as the first decentralised film & entertainment universe that pioneers with its ground-breaking IP co-ownership and "4C" operation model "co-create", "community", "collaborate" and "commercialise".
  • BEAM+ LAB reinvents traditional IP models by decentralising and dispersing IP decision-making to community members (e.g.
  • The innovative decentralised IP model allows holders to partake as co-creators and contributors, which allows them to commercialise their IP ownership (e.g.
  • BEAM+ LAB isexpanding its IP library and co-creation initiatives from movies to arts, animation and much moreto enrich its decentralised film & entertainment universe.

Over 320K USDT in DigitDAO treasury, the first refund proposal will be the best innovation practice for Web3 DAOs

Retrieved on: 
Monday, October 10, 2022

SINGAPORE, Oct. 10, 2022 /PRNewswire/ -- According to the cross-chain DID protocol dotbit(.bit), the first proposal of DigitDAO has been approved by DAO members.

Key Points: 
  • SINGAPORE, Oct. 10, 2022 /PRNewswire/ -- According to the cross-chain DID protocol dotbit(.bit), the first proposal of DigitDAO has been approved by DAO members.
  • This proposal aims to achieve the refund for all registration fees of DigitDAO members' main accounts and invited accounts.
  • DigitDAO has a DAO treasury with stable income, which contains the revenue of all pure digit .bit accounts' registration fees.
  • The adopted proposal could result in a market heat for pure digital .bit accounts since users now can register for pure digit .bit accounts for free.

Over 320K USDT in DigitDAO treasury, the first refund proposal will be the best innovation practice for Web3 DAOs

Retrieved on: 
Monday, October 10, 2022

SINGAPORE, Oct. 10, 2022 /PRNewswire/ -- According to the cross-chain DID protocol dotbit(.bit), the first proposal of DigitDAO has been approved by DAO members.

Key Points: 
  • SINGAPORE, Oct. 10, 2022 /PRNewswire/ -- According to the cross-chain DID protocol dotbit(.bit), the first proposal of DigitDAO has been approved by DAO members.
  • This proposal aims to achieve the refund for all registration fees of DigitDAO members' main accounts and invited accounts.
  • DigitDAO has a DAO treasury with stable income, which contains the revenue of all pure digit .bit accounts' registration fees.
  • The adopted proposal could result in a market heat for pure digital .bit accounts since users now can register for pure digit .bit accounts for free.